Results 11 to 20 of about 298,308 (307)

Liver Biopsy Crash Course

open access: yesMedEdPORTAL, 2016
Introduction We recognized a need at our institution for a resource to facilitate self-learning of basic liver histology and pathology. An interactive, web-based learning module was determined to be an ideal type of educational tool.
Andrew Arifin   +2 more
doaj   +2 more sources

Optical needle biopsy for multimodal detection of malignant liver tumours [PDF]

open access: yes, 2022
Malignant tumours of the liver are one of the most common causes of cancer death worldwide. The presence and type of tumours can be verified only after histological and cytological analysis of a sample obtained during percutaneous needle biopsy. However,
Kandurova, Ksenia   +6 more
core   +1 more source

Elective percutaneous liver biopsy and use of aspirin. [PDF]

open access: yes, 2022
OBJECTIVES Percutaneous liver biopsy is an essential diagnostic investigation in hepatology. Among complications, which are rare, bleeding is the most feared. Many patients scheduled for a liver biopsy are taking aspirin.
Maxence Emmanuel Reynard   +4 more
core   +1 more source

Virtual liver biopsy: image processing and 3D visualization [PDF]

open access: yes, 2001
This paper presents results in the image processing and visualization aspects of a virtual liver biopsy system (a system for simulating the medical procedure of liver biopsy).
Agrafiotis, D   +6 more
core   +1 more source

Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan [PDF]

open access: yes, 2014
There is a need to standardise non-invasive measurements of liver iron concentrations (LIC) so clear inferences can be drawn about body iron levels that are associated with hepatic and extra-hepatic complications of iron overload.
Alam, MH   +15 more
core   +1 more source

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis [PDF]

open access: yes, 2010
Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin). The Enhanced Liver Fibrosis (ELF) test consists of an
Julie Parkes   +12 more
core   +1 more source

Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study

open access: yesInfectious Diseases and Therapy, 2022
Introduction Non-invasive tests (NITs) have been alternative methods of liver biopsy for the cross-sectional assessment of liver fibrosis in patients with chronic hepatitis B (CHB).
Wei Xu   +5 more
doaj   +1 more source

Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?

open access: yesAnnals of Hepatology, 2011
Background. Current practice guidelines recommend liver biopsy prior to treatment of hepatitis C genotype-1 but not for genotype-2/3; this is based on expert opinion, not on published evidence. Methods. In retrospective analysis of a large trial database
Kevork M. Peltekian, Dr.   +9 more
doaj   +1 more source

Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. [PDF]

open access: yes, 2013
Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD.
Richard Schulz   +26 more
core   +1 more source

Transjugular liver biopsy: enlarge the indications for liver biopsy with reliable diagnostic quality

open access: yesBMC Gastroenterology, 2023
Background Complications and diagnostic efficiency for liver biopsy are main concerns for clinicians. This study aimed to assess the safety and efficacy of transjugular liver biopsy (TJLB) compared with percutaneous liver biopsy (PLB) when patients had ...
Miao-Yang Chen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy